Jennifer Culhane
Associate Research Scientist
Research & Publications
Biography
Coauthors
Selected Publications
- For Patients Undergoing an Induction of Labor, Does Increased Body Mass Index Necessitate Higher Doses of Misoprostol? [ID 2683640]Mason-Otey A, Lundsberg L, Culhane J, Merriam A. For Patients Undergoing an Induction of Labor, Does Increased Body Mass Index Necessitate Higher Doses of Misoprostol? [ID 2683640]. Obstetrics And Gynecology 2024, 143: 46s-46s. DOI: 10.1097/01.aog.0001013576.14925.24.
- Association Between Intrapartum Nitrous Oxide for Labor Analgesia and Short-Term Neonatal OutcomesStarosta A, Lundsberg L, Culhane J, Partridge C, Grechukhina O, Son M. Association Between Intrapartum Nitrous Oxide for Labor Analgesia and Short-Term Neonatal Outcomes. Obstetrics And Gynecology 2024, 143: 677-682. PMID: 38484306, DOI: 10.1097/aog.0000000000005554.
- Absence of Adverse Maternal and Neonatal Outcomes in Patients with 1 or 2 Abnormal Values During Early Glucose Tolerance TestingGeng B, Lundsberg L, Culhane J, Merriam A. Absence of Adverse Maternal and Neonatal Outcomes in Patients with 1 or 2 Abnormal Values During Early Glucose Tolerance Testing. American Journal Of Obstetrics And Gynecology 2024, 230: e103-e107. PMID: 38242338, DOI: 10.1016/j.ajog.2024.01.007.
- Co-existing chronic hypertension and hypertensive disorders of pregnancy and associated adverse pregnancy outcomesSweeney L, Lundsberg L, Culhane J, Partridge C, Son M. Co-existing chronic hypertension and hypertensive disorders of pregnancy and associated adverse pregnancy outcomes. The Journal Of Maternal-Fetal & Neonatal Medicine 2024, 37: 2305675. PMID: 38290827, DOI: 10.1080/14767058.2024.2305675.
- 284 Postpartum diabetes screening rates and 1-year outcomes for individuals with early onset gestational diabetesPifer B, Geng B, Lundsberg L, Culhane J, Partridge C, Merriam A. 284 Postpartum diabetes screening rates and 1-year outcomes for individuals with early onset gestational diabetes. American Journal Of Obstetrics And Gynecology 2024, 230: s163-s164. DOI: 10.1016/j.ajog.2023.11.306.
- 1083 Risk of Severe Maternal Morbidity in Polycystic Ovary SyndromeMcKenney K, Culhane J, Son M, Dysart K. 1083 Risk of Severe Maternal Morbidity in Polycystic Ovary Syndrome. American Journal Of Obstetrics And Gynecology 2024, 230: s568-s569. DOI: 10.1016/j.ajog.2023.11.1110.
- 599 Differing clinical management for postpartum hemorrhage and associated risk for intensive care unit admissionSon M, Lundsberg L, Dysart K, Partridge C, Burris H, Handley S, Ledyard R, Baisden K, Berhane L, Doamekpor L, Bersoff-Matcha S, Culhane J. 599 Differing clinical management for postpartum hemorrhage and associated risk for intensive care unit admission. American Journal Of Obstetrics And Gynecology 2024, 230: s324-s325. DOI: 10.1016/j.ajog.2023.11.624.
- 715 Trends in Tdap and Flu Vaccination in Pregnant People in Relation to the COVID-19 PandemicDave E, Culhane J, Lundsberg L, Partridge C, Kohari K, Denoble A. 715 Trends in Tdap and Flu Vaccination in Pregnant People in Relation to the COVID-19 Pandemic. American Journal Of Obstetrics And Gynecology 2024, 230: s382. DOI: 10.1016/j.ajog.2023.11.741.
- 597 De novo hypertension in the late postpartum period: a case for extending postpartum careSinnott C, Stammler S, Lundsberg L, Partridge C, Culhane J, Denoble A. 597 De novo hypertension in the late postpartum period: a case for extending postpartum care. American Journal Of Obstetrics And Gynecology 2024, 230: s323-s324. DOI: 10.1016/j.ajog.2023.11.622.
- 983 Maternal characteristics associated with delivery versus expectant management when presenting with term decreased fetal movementDing J, Lundsberg L, Culhane J, Partridge C, Cross S. 983 Maternal characteristics associated with delivery versus expectant management when presenting with term decreased fetal movement. American Journal Of Obstetrics And Gynecology 2024, 230: s518-s519. DOI: 10.1016/j.ajog.2023.11.1010.
- 601 Evolution of hypertension stages in pregnancy and postpartum from 2013-2022Stammler S, Denoble A, Culhane J, Lundsberg L, Partridge C. 601 Evolution of hypertension stages in pregnancy and postpartum from 2013-2022. American Journal Of Obstetrics And Gynecology 2024, 230: s325-s326. DOI: 10.1016/j.ajog.2023.11.626.
- 427 Delivery and neonatal outcomes associated with delivery versus expectant management following term decreased fetal movementDing J, Lundsberg L, Culhane J, Partridge C, Cross S. 427 Delivery and neonatal outcomes associated with delivery versus expectant management following term decreased fetal movement. American Journal Of Obstetrics And Gynecology 2024, 230: s236. DOI: 10.1016/j.ajog.2023.11.453.
- 425 Effect of the COVID-19 pandemic on population-level mean arterial pressure during pregnancy and postpartumDenoble A, Stammler S, Partridge C, Lundsberg L, Culhane J. 425 Effect of the COVID-19 pandemic on population-level mean arterial pressure during pregnancy and postpartum. American Journal Of Obstetrics And Gynecology 2024, 230: s235. DOI: 10.1016/j.ajog.2023.11.451.
- 426 Brain natriuretic peptide testing and severe maternal morbidity in pregnancies affected by heart diseaseDenoble A, Federspiel J, Goldstein S, Culhane J, Dysart K. 426 Brain natriuretic peptide testing and severe maternal morbidity in pregnancies affected by heart disease. American Journal Of Obstetrics And Gynecology 2024, 230: s235-s236. DOI: 10.1016/j.ajog.2023.11.452.